Press release Ecully, 7 September 2017
Continued expansion in the USA
New distributor in Texas
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just signed its fourth distribution agreement in the USA with a distributor in Texas.
Established over 20 years ago, this new partner has a significant network in Texas and a solid understanding of the spinal surgery market. Its sales revenue exceeds 10 million dollars. Its large client portfolio provides Spineway with interesting prospects for its continued development.
Thanks to this new distributor, the Group's US subsidiary is strengthening its position as it progressively increases its coverage of the US territory.
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES)
Find out all about Spineway at www.spineway.com
Next communication:
2017 First Semester Results - 26 October 2017, after market closes
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) - Talent INPI award (2015).
ISIN code: FR0011398874 - Euronext Growth
Contacts:
| Investor Relations David Siegrist - Finance Director +33 (0)4 72 77 01 52 finance.dsg@spineway.com | Financial Communication Jérôme Gacoin / Solène Kennis +33 (0)1 75 77 54 68 skennis@aelium.fr |
